Pregnancy , childbirth and the puerperium (O00-O99). failed induction of labour
Conditions
Interventions
Intervention 1: The control group: will recieve vaginal supositories containing 25 microgram misoprostol and sublingual tablets of placebo. Intervention 2: The intervention group: will recieve 25 micr
Treatment - Drugs
The control group: will recieve vaginal supositories containing 25 microgram misoprostol and sublingual tablets of placebo.
The intervention group: will recieve 25 microgram tablets of misoprostol and vaginal supositories containing placebo.
Sponsors
Shiraz University of Medical Sciences- Vice Chancellor for Research
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:first singleton alive pregnancy; gestational age of =37 weeks: cephalic presentation: estimated fetal weight of less than 4000 grams; Bishop Score <7. Exclusion criteria: : hypersensitivity to prostaglandins; previous uterine scar; fetal congenital malformations; intrauterine growth restriction; non-reassuring fetal heart; gestational age <37 weeks; oligohydramnious.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The time needed for delivery. Timepoint: Medication starting time to delivery. Method of measurement: Measurement of the time needed after aplication of medication to delivery.;Fetal safety. Timepoint: at delivery. Method of measurement: By evaluation of neonata blood gas at birth. | — |
Secondary
| Measure | Time frame |
|---|---|
| The effect of drugs on the fetal safety. Timepoint: After birth. Method of measurement: Apgar scors and NICU admissions.;Fetal safety. Timepoint: during labor. Method of measurement: meconium passage. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Bahia Namavar Jahromi
School of Medicine, Shiraz University of Medical Sciences
Outcome results
None listed